Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Hematologic Neoplasms 1Heart Failure 1Cardiomyopathies 1Breast Neoplasms 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 2dapagliflozin 2Rituximab 2pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1acalabrutinib 1Vincristine 1Valsartan 1Trastuzumab 1Standard of Care 1Specimen Handling 1Pyruvic Acid 1Prednisolone 1Practice Guidelines as Topic 1Ogivri 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1Eplerenone 1Electronic Health Records 1Echocardiography 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Cardiac Resynchronization Therapy 1Angiotensin-Converting Enzyme Inhibitors 1Adrenergic beta-Antagonists 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Heart Failure × Electronic Health Records × Clear all
NCT05507879 2026-02-10

TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer

Mayo Clinic

Recruiting
200 enrolled
Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡